496 related articles for article (PubMed ID: 12742997)
21. Induction of atherosclerosis by low-fat, semisynthetic diets in LDL receptor-deficient C57BL/6J and FVB/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement).
Teupser D; Persky AD; Breslow JL
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1907-13. PubMed ID: 12907460
[TBL] [Abstract][Full Text] [Related]
22. Suppression of atherogenesis by delivery of TGFbeta1ACT using adeno-associated virus type 2 in LDLR knockout mice.
Li D; Liu Y; Chen J; Velchala N; Amani F; Nemarkommula A; Chen K; Rayaz H; Zhang D; Liu H; Sinha AK; Romeo F; Hermonat PL; Mehta JL
Biochem Biophys Res Commun; 2006 Jun; 344(3):701-7. PubMed ID: 16631603
[TBL] [Abstract][Full Text] [Related]
23. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.
Paul A; Ko KW; Li L; Yechoor V; McCrory MA; Szalai AJ; Chan L
Circulation; 2004 Feb; 109(5):647-55. PubMed ID: 14744975
[TBL] [Abstract][Full Text] [Related]
24. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.
Berthou L; Duverger N; Emmanuel F; Langouët S; Auwerx J; Guillouzo A; Fruchart JC; Rubin E; Denèfle P; Staels B; Branellec D
J Clin Invest; 1996 Jun; 97(11):2408-16. PubMed ID: 8647932
[TBL] [Abstract][Full Text] [Related]
25. Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia.
Lebherz C; Gao G; Louboutin JP; Millar J; Rader D; Wilson JM
J Gene Med; 2004 Jun; 6(6):663-72. PubMed ID: 15170737
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.
Rubin EM; Krauss RM; Spangler EA; Verstuyft JG; Clift SM
Nature; 1991 Sep; 353(6341):265-7. PubMed ID: 1910153
[TBL] [Abstract][Full Text] [Related]
27. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
Valenta DT; Ogier N; Bradshaw G; Black AS; Bonnet DJ; Lagrost L; Curtiss LK; Desrumaux CM
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1572-8. PubMed ID: 16675720
[TBL] [Abstract][Full Text] [Related]
28. Administration of pioglitazone in low-density lipoprotein receptor-deficient mice inhibits lesion progression and matrix metalloproteinase expression in advanced atherosclerotic plaques.
He L; Game BA; Nareika A; Garvey WT; Huang Y
J Cardiovasc Pharmacol; 2006 Nov; 48(5):212-22. PubMed ID: 17110803
[TBL] [Abstract][Full Text] [Related]
29. Endothelial nitric oxide synthase gene transfer restores endothelium-dependent relaxations and attenuates lesion formation in carotid arteries in apolipoprotein E-deficient mice.
Mujynya-Ludunge K; Viswambharan H; Driscoll R; Ming XF; von Segesser LK; Kappenberger L; Yang Z; Vassalli G
Basic Res Cardiol; 2005 Mar; 100(2):102-11. PubMed ID: 15578196
[TBL] [Abstract][Full Text] [Related]
30. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y
Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699
[TBL] [Abstract][Full Text] [Related]
31. Alcohol feeding impedes early atherosclerosis in low-density lipoprotein receptor knockout mice: factors in addition to high-density lipoprotein-apolipoprotein A1 are involved.
Dai J; Miller BA; Lin RC
Alcohol Clin Exp Res; 1997 Feb; 21(1):11-8. PubMed ID: 9046367
[TBL] [Abstract][Full Text] [Related]
32. Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice.
Guo H; Shi Y; Liu L; Sun A; Xu F; Chi J
Arch Med Res; 2009 Jul; 40(5):345-51. PubMed ID: 19766896
[TBL] [Abstract][Full Text] [Related]
33. Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor.
Oka K; Pastore L; Kim IH; Merched A; Nomura S; Lee HJ; Merched-Sauvage M; Arden-Riley C; Lee B; Finegold M; Beaudet A; Chan L
Circulation; 2001 Mar; 103(9):1274-81. PubMed ID: 11238273
[TBL] [Abstract][Full Text] [Related]
34. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model.
Albrecht C; Preusch MR; Hofmann G; Morris-Rosenfeld S; Blessing E; Rosenfeld ME; Katus HA; Bea F
Cardiovasc Res; 2010 May; 86(2):321-9. PubMed ID: 20110335
[TBL] [Abstract][Full Text] [Related]
35. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
[TBL] [Abstract][Full Text] [Related]
36. Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis.
Navab M; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Hough G; Wagner A; Nakamura K; Garber DW; Datta G; Segrest JP; Hama S; Fogelman AM
Curr Opin Investig Drugs; 2003 Sep; 4(9):1100-4. PubMed ID: 14582455
[TBL] [Abstract][Full Text] [Related]
37. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice.
Tangirala RK; Tsukamoto K; Chun SH; Usher D; Puré E; Rader DJ
Circulation; 1999 Oct; 100(17):1816-22. PubMed ID: 10534470
[TBL] [Abstract][Full Text] [Related]
38. Trimerization of apolipoprotein A-I retards plasma clearance and preserves antiatherosclerotic properties.
Graversen JH; Laurberg JM; Andersen MH; Falk E; Nieland J; Christensen J; Etzerodt M; Thøgersen HC; Moestrup SK
J Cardiovasc Pharmacol; 2008 Feb; 51(2):170-7. PubMed ID: 18287885
[TBL] [Abstract][Full Text] [Related]
39. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice.
Schultz JR; Verstuyft JG; Gong EL; Nichols AV; Rubin EM
Nature; 1993 Oct; 365(6448):762-4. PubMed ID: 8413656
[TBL] [Abstract][Full Text] [Related]
40. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia.
Kypreos KE
Biochemistry; 2008 Sep; 47(39):10491-502. PubMed ID: 18767813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
